Atopic Dermatitis Treatment Market 2027 by Drug Class, Route of Administration, Distribution Channel and Geography | The Insight Partners

Atopic Dermatitis Treatment Market to 2027 - Global Analysis and Forecasts By Drug Class ( Corticosteroids, Calcineurin Inhibitors, Immunosuppressant, Biologic Therapy, PDE-4 Inhibitor, Antibiotics, Antihistamines, Emollients ); Route of Administration ( Topical, Oral, Injectable ); Distribution Channel ( Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Drug Stores, Mail Order Pharmacies, Dermatology Clinics ) and Geography

Report Code: TIPRE00006854 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION

Atopic dermatitis is a chronic skin disease which in most of the cases begins in childhood. This medical condition is special type of allergic hypersensitivity which is associated with inhalant allergies, asthma, and chronic dermatitis. Its symptoms include itching, plaques on skin and others. Medications used to treat atopic dermatitis are topical creams, oral drugs and injectable biologics.

MARKET DYNAMICS

The atopic dermatitis treatment market is anticipated to grow in the forecast, owing increasing demand for In vitro Diagnostics (IVD) for diagnosis of chronic diseases, rising prevalence of genetic diseases and increasing research on in vitro diagnostics. In addition, technological advancements in Atopic Dermatitis Treatment technique is expected to offer significant growth opportunities in the market during the forecast period.

MARKET SCOPE

The "Atopic Dermatitis Treatment Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of atopic dermatitis treatment market with detailed market segmentation by drug class, route of administration, distribution channel and geography. The atopic dermatitis treatment market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading atopic dermatitis treatment market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The atopic dermatitis treatment market is segmented on the basis of drug class, route of administration, distribution channel. Based on drug class the market is segmented as corticosteroids, calcineurin inhibitors, immunosuppressant, biologic therapy, PDE-4 inhibitor, antibiotics, antihistamines, emollients. On the basis of route of administration the market is segmented into topical, oral and injectable. Based on distribution channel, the atopic dermatitis treatment market is segmented into hospital pharmacies, retail pharmacies, online pharmacies, drug stores, mail order pharmacies and dermatology clinics.

REGIONAL FRAMEWORK


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Atopic Dermatitis Treatment market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Atopic Dermatitis Treatment market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Atopic Dermatitis Treatment market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Atopic Dermatitis Treatment market in these regions.

MARKET PLAYERS


The report covers key developments in the Atopic Dermatitis Treatment market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Atopic Dermatitis Treatment market are anticipated to have lucrative growth opportunities in the future with the rising demand for Atopic Dermatitis Treatment market in the global market. Below mentioned is the list of few companies engaged in the Atopic Dermatitis Treatment market.

The report also includes the profiles of key Atopic Dermatitis Treatment market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Sanofi SA
  •  Allergan Plc.
  •  Novartis International AG
  •  Bristol-Myers Squibb
  •  Bayer AG
  •  Meda Pharmaceuticals
  •  Anacor Pharmaceutical Inc.
  •  Pfizer
  •  Astellas Pharma Inc.
  •  Regeneron Pharmaceuticals
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
Table of Content

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Atopic Dermatitis Treatment Market - By Drug Class
1.3.2 Atopic Dermatitis Treatment Market - By Route of Administration
1.3.3 Atopic Dermatitis Treatment Market - By Distribution Channel
1.3.4 Atopic Dermatitis Treatment Market - By Region
1.3.4.1 By Country

2. KEY TAKEAWAYS


3. RESEARCH METHODOLOGY


4. ATOPIC DERMATITIS TREATMENT MARKET LANDSCAPE

4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. ATOPIC DERMATITIS TREATMENT MARKET - KEY MARKET DYNAMICS

5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. ATOPIC DERMATITIS TREATMENT MARKET - GLOBAL MARKET ANALYSIS

6.1. ATOPIC DERMATITIS TREATMENT - GLOBAL MARKET OVERVIEW
6.2. ATOPIC DERMATITIS TREATMENT - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. ATOPIC DERMATITIS TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - DRUG CLASS

7.1. OVERVIEW
7.2. DRUG CLASS MARKET FORECASTS AND ANALYSIS
7.3. CORTICOSTEROIDS
7.3.1. Overview
7.3.2. Corticosteroids Market Forecast and Analysis
7.4. CALCINEURIN INHIBITORS
7.4.1. Overview
7.4.2. Calcineurin Inhibitors Market Forecast and Analysis
7.5. IMMUNOSUPPRESSANT
7.5.1. Overview
7.5.2. Immunosuppressant Market Forecast and Analysis
7.6. BIOLOGIC THERAPY
7.6.1. Overview
7.6.2. Biologic Therapy Market Forecast and Analysis
7.7. PDE-4 INHIBITOR
7.7.1. Overview
7.7.2. PDE-4 Inhibitor Market Forecast and Analysis
7.8. ANTIBIOTICS
7.8.1. Overview
7.8.2. Antibiotics Market Forecast and Analysis
7.9. ANTIHISTAMINES
7.9.1. Overview
7.9.2. Antihistamines Market Forecast and Analysis
7.10. EMOLLIENTS
7.10.1. Overview
7.10.2. Emollients Market Forecast and Analysis

8. ATOPIC DERMATITIS TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - ROUTE OF ADMINISTRATION

8.1. OVERVIEW
8.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
8.3. TOPICAL
8.3.1. Overview
8.3.2. Topical Market Forecast and Analysis
8.4. ORAL
8.4.1. Overview
8.4.2. Oral Market Forecast and Analysis
8.5. INJECTABLE
8.5.1. Overview
8.5.2. Injectable Market Forecast and Analysis

9. ATOPIC DERMATITIS TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL

9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. HOSPITAL PHARMACIES
9.3.1. Overview
9.3.2. Hospital Pharmacies Market Forecast and Analysis
9.4. RETAIL PHARMACIES
9.4.1. Overview
9.4.2. Retail Pharmacies Market Forecast and Analysis
9.5. ONLINE PHARMACIES
9.5.1. Overview
9.5.2. Online Pharmacies Market Forecast and Analysis
9.6. DRUG STORES
9.6.1. Overview
9.6.2. Drug Stores Market Forecast and Analysis
9.7. MAIL ORDER PHARMACIES
9.7.1. Overview
9.7.2. Mail Order Pharmacies Market Forecast and Analysis
9.8. DERMATOLOGY CLINICS
9.8.1. Overview
9.8.2. Dermatology Clinics Market Forecast and Analysis

10. ATOPIC DERMATITIS TREATMENT MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS

10.1. NORTH AMERICA
10.1.1 North America Atopic Dermatitis Treatment Market Overview
10.1.2 North America Atopic Dermatitis Treatment Market Forecasts and Analysis
10.1.3 North America Atopic Dermatitis Treatment Market Forecasts and Analysis - By Drug Class
10.1.4 North America Atopic Dermatitis Treatment Market Forecasts and Analysis - By Route of Administration
10.1.5 North America Atopic Dermatitis Treatment Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Atopic Dermatitis Treatment Market Forecasts and Analysis - By Countries
10.1.6.1 United States Atopic Dermatitis Treatment Market
10.1.6.1.1 United States Atopic Dermatitis Treatment Market by Drug Class
10.1.6.1.2 United States Atopic Dermatitis Treatment Market by Route of Administration
10.1.6.1.3 United States Atopic Dermatitis Treatment Market by Distribution Channel
10.1.6.2 Canada Atopic Dermatitis Treatment Market
10.1.6.2.1 Canada Atopic Dermatitis Treatment Market by Drug Class
10.1.6.2.2 Canada Atopic Dermatitis Treatment Market by Route of Administration
10.1.6.2.3 Canada Atopic Dermatitis Treatment Market by Distribution Channel
10.1.6.3 Mexico Atopic Dermatitis Treatment Market
10.1.6.3.1 Mexico Atopic Dermatitis Treatment Market by Drug Class
10.1.6.3.2 Mexico Atopic Dermatitis Treatment Market by Route of Administration
10.1.6.3.3 Mexico Atopic Dermatitis Treatment Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Atopic Dermatitis Treatment Market Overview
10.2.2 Europe Atopic Dermatitis Treatment Market Forecasts and Analysis
10.2.3 Europe Atopic Dermatitis Treatment Market Forecasts and Analysis - By Drug Class
10.2.4 Europe Atopic Dermatitis Treatment Market Forecasts and Analysis - By Route of Administration
10.2.5 Europe Atopic Dermatitis Treatment Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Atopic Dermatitis Treatment Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Atopic Dermatitis Treatment Market
10.2.6.1.1 Germany Atopic Dermatitis Treatment Market by Drug Class
10.2.6.1.2 Germany Atopic Dermatitis Treatment Market by Route of Administration
10.2.6.1.3 Germany Atopic Dermatitis Treatment Market by Distribution Channel
10.2.6.2 France Atopic Dermatitis Treatment Market
10.2.6.2.1 France Atopic Dermatitis Treatment Market by Drug Class
10.2.6.2.2 France Atopic Dermatitis Treatment Market by Route of Administration
10.2.6.2.3 France Atopic Dermatitis Treatment Market by Distribution Channel
10.2.6.3 Italy Atopic Dermatitis Treatment Market
10.2.6.3.1 Italy Atopic Dermatitis Treatment Market by Drug Class
10.2.6.3.2 Italy Atopic Dermatitis Treatment Market by Route of Administration
10.2.6.3.3 Italy Atopic Dermatitis Treatment Market by Distribution Channel
10.2.6.4 Spain Atopic Dermatitis Treatment Market
10.2.6.4.1 Spain Atopic Dermatitis Treatment Market by Drug Class
10.2.6.4.2 Spain Atopic Dermatitis Treatment Market by Route of Administration
10.2.6.4.3 Spain Atopic Dermatitis Treatment Market by Distribution Channel
10.2.6.5 United Kingdom Atopic Dermatitis Treatment Market
10.2.6.5.1 United Kingdom Atopic Dermatitis Treatment Market by Drug Class
10.2.6.5.2 United Kingdom Atopic Dermatitis Treatment Market by Route of Administration
10.2.6.5.3 United Kingdom Atopic Dermatitis Treatment Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Atopic Dermatitis Treatment Market Overview
10.3.2 Asia-Pacific Atopic Dermatitis Treatment Market Forecasts and Analysis
10.3.3 Asia-Pacific Atopic Dermatitis Treatment Market Forecasts and Analysis - By Drug Class
10.3.4 Asia-Pacific Atopic Dermatitis Treatment Market Forecasts and Analysis - By Route of Administration
10.3.5 Asia-Pacific Atopic Dermatitis Treatment Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Atopic Dermatitis Treatment Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Atopic Dermatitis Treatment Market
10.3.6.1.1 Australia Atopic Dermatitis Treatment Market by Drug Class
10.3.6.1.2 Australia Atopic Dermatitis Treatment Market by Route of Administration
10.3.6.1.3 Australia Atopic Dermatitis Treatment Market by Distribution Channel
10.3.6.2 China Atopic Dermatitis Treatment Market
10.3.6.2.1 China Atopic Dermatitis Treatment Market by Drug Class
10.3.6.2.2 China Atopic Dermatitis Treatment Market by Route of Administration
10.3.6.2.3 China Atopic Dermatitis Treatment Market by Distribution Channel
10.3.6.3 India Atopic Dermatitis Treatment Market
10.3.6.3.1 India Atopic Dermatitis Treatment Market by Drug Class
10.3.6.3.2 India Atopic Dermatitis Treatment Market by Route of Administration
10.3.6.3.3 India Atopic Dermatitis Treatment Market by Distribution Channel
10.3.6.4 Japan Atopic Dermatitis Treatment Market
10.3.6.4.1 Japan Atopic Dermatitis Treatment Market by Drug Class
10.3.6.4.2 Japan Atopic Dermatitis Treatment Market by Route of Administration
10.3.6.4.3 Japan Atopic Dermatitis Treatment Market by Distribution Channel
10.3.6.5 South Korea Atopic Dermatitis Treatment Market
10.3.6.5.1 South Korea Atopic Dermatitis Treatment Market by Drug Class
10.3.6.5.2 South Korea Atopic Dermatitis Treatment Market by Route of Administration
10.3.6.5.3 South Korea Atopic Dermatitis Treatment Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Atopic Dermatitis Treatment Market Overview
10.4.2 Middle East and Africa Atopic Dermatitis Treatment Market Forecasts and Analysis
10.4.3 Middle East and Africa Atopic Dermatitis Treatment Market Forecasts and Analysis - By Drug Class
10.4.4 Middle East and Africa Atopic Dermatitis Treatment Market Forecasts and Analysis - By Route of Administration
10.4.5 Middle East and Africa Atopic Dermatitis Treatment Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Atopic Dermatitis Treatment Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Atopic Dermatitis Treatment Market
10.4.6.1.1 South Africa Atopic Dermatitis Treatment Market by Drug Class
10.4.6.1.2 South Africa Atopic Dermatitis Treatment Market by Route of Administration
10.4.6.1.3 South Africa Atopic Dermatitis Treatment Market by Distribution Channel
10.4.6.2 Saudi Arabia Atopic Dermatitis Treatment Market
10.4.6.2.1 Saudi Arabia Atopic Dermatitis Treatment Market by Drug Class
10.4.6.2.2 Saudi Arabia Atopic Dermatitis Treatment Market by Route of Administration
10.4.6.2.3 Saudi Arabia Atopic Dermatitis Treatment Market by Distribution Channel
10.4.6.3 U.A.E Atopic Dermatitis Treatment Market
10.4.6.3.1 U.A.E Atopic Dermatitis Treatment Market by Drug Class
10.4.6.3.2 U.A.E Atopic Dermatitis Treatment Market by Route of Administration
10.4.6.3.3 U.A.E Atopic Dermatitis Treatment Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Atopic Dermatitis Treatment Market Overview
10.5.2 South and Central America Atopic Dermatitis Treatment Market Forecasts and Analysis
10.5.3 South and Central America Atopic Dermatitis Treatment Market Forecasts and Analysis - By Drug Class
10.5.4 South and Central America Atopic Dermatitis Treatment Market Forecasts and Analysis - By Route of Administration
10.5.5 South and Central America Atopic Dermatitis Treatment Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Atopic Dermatitis Treatment Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Atopic Dermatitis Treatment Market
10.5.6.1.1 Brazil Atopic Dermatitis Treatment Market by Drug Class
10.5.6.1.2 Brazil Atopic Dermatitis Treatment Market by Route of Administration
10.5.6.1.3 Brazil Atopic Dermatitis Treatment Market by Distribution Channel
10.5.6.2 Argentina Atopic Dermatitis Treatment Market
10.5.6.2.1 Argentina Atopic Dermatitis Treatment Market by Drug Class
10.5.6.2.2 Argentina Atopic Dermatitis Treatment Market by Route of Administration
10.5.6.2.3 Argentina Atopic Dermatitis Treatment Market by Distribution Channel

11. INDUSTRY LANDSCAPE

11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

12. ATOPIC DERMATITIS TREATMENT MARKET, KEY COMPANY PROFILES

12.1. SANOFI SA
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. ALLERGAN PLC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. NOVARTIS INTERNATIONAL AG
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. BRISTOL-MYERS SQUIBB
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. BAYER AG
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. MEDA PHARMACEUTICALS
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. ANACOR PHARMACEUTICAL INC.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. PFIZER
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. ASTELLAS PHARMA INC.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. REGENERON PHARMACEUTICALS
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments

13. APPENDIX

13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Sanofi SA
2. Allergan Plc.
3. Novartis International AG
4. Bristol-Myers Squibb
5. Bayer AG
6. Meda Pharmaceuticals
7. Anacor Pharmaceutical Inc.
8. Pfizer
9. Astellas Pharma Inc.
10. Regeneron Pharmaceuticals